Ensign Peak Advisors Inc Acquires 14,322 Shares of Kenvue Inc. (NYSE:KVUE)

Ensign Peak Advisors Inc raised its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 9.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 169,137 shares of the company's stock after purchasing an additional 14,322 shares during the period. Ensign Peak Advisors Inc's holdings in Kenvue were worth $3,611,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of KVUE. Kiley Juergens Wealth Management LLC boosted its position in shares of Kenvue by 1.9% during the fourth quarter. Kiley Juergens Wealth Management LLC now owns 27,110 shares of the company's stock valued at $579,000 after buying an additional 500 shares during the last quarter. Principle Wealth Partners LLC grew its stake in shares of Kenvue by 3.7% in the fourth quarter. Principle Wealth Partners LLC now owns 14,194 shares of the company's stock worth $303,000 after acquiring an additional 500 shares during the period. White Pine Capital LLC raised its holdings in shares of Kenvue by 1.0% during the fourth quarter. White Pine Capital LLC now owns 54,572 shares of the company's stock valued at $1,165,000 after purchasing an additional 542 shares during the last quarter. Deseret Mutual Benefit Administrators lifted its position in Kenvue by 29.0% during the fourth quarter. Deseret Mutual Benefit Administrators now owns 2,528 shares of the company's stock valued at $54,000 after purchasing an additional 568 shares during the period. Finally, SRS Capital Advisors Inc. boosted its holdings in Kenvue by 67.4% in the fourth quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company's stock worth $30,000 after purchasing an additional 571 shares during the last quarter. Institutional investors own 97.64% of the company's stock.

Analyst Ratings Changes

A number of brokerages have weighed in on KVUE. Royal Bank of Canada reiterated a "sector perform" rating and set a $24.00 target price on shares of Kenvue in a research note on Monday, February 3rd. Evercore ISI started coverage on Kenvue in a research note on Monday, March 24th. They set an "in-line" rating and a $25.00 price target for the company. UBS Group raised their price objective on shares of Kenvue from $24.00 to $25.00 and gave the stock a "neutral" rating in a report on Friday, May 9th. Barclays upped their target price on shares of Kenvue from $22.00 to $23.00 and gave the company an "equal weight" rating in a report on Monday, May 12th. Finally, Piper Sandler lifted their price target on shares of Kenvue from $24.00 to $27.00 and gave the stock an "overweight" rating in a research note on Monday, February 24th. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, Kenvue presently has a consensus rating of "Hold" and a consensus target price of $25.33.

Kenvue Trading Up 0.4%

NYSE KVUE traded up $0.11 during trading on Tuesday, hitting $24.11. The stock had a trading volume of 3,666,361 shares, compared to its average volume of 16,468,366. Kenvue Inc. has a one year low of $17.67 and a one year high of $25.17. The stock has a market capitalization of $46.25 billion, a price-to-earnings ratio of 45.48, a P/E/G ratio of 2.62 and a beta of 1.02. The stock has a 50 day simple moving average of $23.18 and a 200 day simple moving average of $22.60. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00.

Kenvue (NYSE:KVUE - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $0.24 EPS for the quarter, topping analysts' consensus estimates of $0.23 by $0.01. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. The business had revenue of $3.74 billion for the quarter, compared to the consensus estimate of $3.69 billion. During the same period in the prior year, the firm earned $0.28 EPS. The company's revenue for the quarter was down 3.9% compared to the same quarter last year. Sell-side analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th will be given a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a yield of 3.40%. The ex-dividend date is Wednesday, May 14th. Kenvue's dividend payout ratio (DPR) is presently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.